Cooper CompaniesCOO
Market Cap: $21.2B
About: CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.
Employees: 15,000
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
65% more first-time investments, than exits
New positions opened: 94 | Existing positions closed: 57
38% more repeat investments, than reductions
Existing positions increased: 259 | Existing positions reduced: 188
6% more funds holding
Funds holding: 578 [Q1] → 615 (+37) [Q2]
2.53% more ownership
Funds ownership: 94.53% [Q1] → 97.06% (+2.53%) [Q2]
12% less capital invested
Capital invested by funds: $19B [Q1] → $16.9B (-$2.19B) [Q2]
33% less funds holding in top 10
Funds holding in top 10: 6 [Q1] → 4 (-2) [Q2]
43% less call options, than puts
Call options by funds: $26.1M | Put options by funds: $45.6M
Research analyst outlook
6 Wall Street Analysts provided 1 year price targets over the past 3 months
6 analyst ratings
Stifel Jonathan Block 50% 1-year accuracy 13 / 26 met price target | 8%upside $115 | Buy Reiterated | 29 Aug 2024 |
Piper Sandler Jason Bednar 45% 1-year accuracy 18 / 40 met price target | 13%upside $120 | Overweight Reiterated | 29 Aug 2024 |
Wells Fargo Larry Biegelsen 68% 1-year accuracy 25 / 37 met price target | 8%upside $115 | Overweight Maintained | 29 Aug 2024 |
Baird Jeff Johnson 58% 1-year accuracy 7 / 12 met price target | 17%upside $125 | Outperform Maintained | 29 Aug 2024 |
Jefferies Young Li 100% 1-year accuracy 1 / 1 met price target | 8%upside $115 | Buy Upgraded | 16 Jul 2024 |
Financial journalist opinion
Based on 14 articles about COO published over the past 30 days